| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-09-24 | S 81694 (NMS-P153) | advanced or metastatic solid tumors who have failed previous therapies | 1 | Servier (France) Nerviano Medical Sciences (Italy) | Cancer - Oncology |
| 2015-09-23 | ADX71149 | epilepsy | preclinical | Addex Therapeutics (Switzerland) Janssen Pharmaceuticals, a J&J company (USA - NJ) | Neurological diseases - CNS diseases |
| 2015-09-23 | apatorsen (OGX-427) | pancreatic cancer | 2 | OncoGenex Pharmaceuticals (USA - WA) | Cancer - Oncology |
| 2015-09-23 | ABP 215 (bevacizumab - biosimilar version of Avastin®) | metastatic non small cell lung cancer | 3 | Amgen (USA - CA) Allergan (Ireland) | Cancer - Oncology |
| 2015-09-22 | PXS4728A | NASH (non-alcoholic steatohepatitis) | 1 | Pharmaxis (Australia) | Liver diseases - Hepatic diseases |
| 2015-09-22 | GLPG1690 | chronic obstructive pulmonary disease (COPD) | 1 | Galapagos (Belgium) Janssen Pharmaceutica, a J&J company (USA - NJ) | Lung diseases - Respiratory diseases |
| 2015-09-21 | Envarsus® XR (previously LCP-Tacro™) (tacrolimus) | prevention of graft rejection in kidney transplantation | 3b | Veloxis Pharmaceuticals (Denmark) | Transplantation |
| 2015-09-21 | NKTR-214 | preclinical | Nektar Therapeutics (USA - CA) | Cancer - Oncology | |
| 2015-09-21 | ITI-214 | 1 | Intra-Cellular Therapies (USA - NY) | CNS diseases - Mental diseases | |
| 2015-09-21 | masitinib | rheumatoid arthritis | 3 | AB Science (France) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2015-09-21 | BGB324 in combination with immune checkpoint inhibitors | preclinical | BergenBio (Norway) | Cancer - Oncology | |
| 2015-09-21 | sofosbuvir and velpatasvir | genotype 1-6 chronic hepatitis C virus (HCV) infection | 3 | Gilead (USA - CA) | Infectious diseases |
| 2015-09-20 | bezlotoxumab | Clostridium Difficile infection recurrence | 3 | Merck&Co (USA - NJ) | Infectious diseases |
| 2015-09-19 | delafloxacin | preclinical | Melinta Therapeutics (USA - CT) | Infectious diseases | |
| 2015-09-19 | adeno-associated viral 5 (AAV5) gene therapy - AMT-110 | Sanfilippo B syndrome (rare autosomal recessive lysosomal storage disease, which manifests in young children) | 1-2 | Institut Pasteur (France) Inserm (France) AFM-Téléthon (France) Vaincre les Maladies Lysosomales (VML) (France) Uniqure (The Netherlands) | Rare diseases |
| 2015-09-19 | CureXcell® | chronic venous leg ulcers | 3 | Macrocure (Israel) | Cardiovascular diseases |
| 2015-09-18 | Ad-RTS-IL-12 | advanced melanoma, breast cancer, glioblastoma, colon cancer | preclinical, 2 | Ziopharm Oncology (USA - MA) | Cancer - Oncology |
| 2015-09-18 | bacteriophage cocktail against Staphylococcus aureus | preclinical | AmpliPhi BioSciences (USA - VA) | Infectious diseases | |
| 2015-09-18 | pembrolizumab (MK-3475) | metastatic triple negative breast cancer | 3 | Merck&Co (USA - NJ) | Cancer - Oncology |
| 2015-09-17 | VGX-3100 | cervical intraepithelial neoplasia 2/3 (CIN2/3) associated with human papillomavirus (HPV) types 16 or 18 | 2b | Inovio Pharmaceuticals (USA - PA) | Infectious diseases - Women health - Cancer - Oncology |
